Streptococcus pneumoniae meningitis resistant to penicillin clinical and microbiological characteristics;Caracteristicas clinico-microbiologicas de la meningitis par Streptococcus pneumoniae resistente a la penicilina

Salud Publica de Mexico

Volumn 41, Issue 5, 1999, Pages 397-404

  Gómez Barreto, Demóstenes ^a   Calderón Jaimes, Ernesto ^b   Rodríguez, Romeo S ^b   De Los Monteros, Luz Elena Espinosa ^b   Juárez, Maricruz ^b  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b NONE

Author keywords

Mexico; Penicillin resistance; Pneumococcal meningitis

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID EXAMINATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INFANT; MALE; MEXICO; MORTALITY; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; CEREBROSPINAL FLUID; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PENICILLIN RESISTANCE; PRESCHOOL CHILD; PROSPECTIVE STUDY;

CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; INFANT; MALE; MENINGITIS, BACTERIAL; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE;

EID: 0344563469     PISSN: 00363634     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Zangwill KM, Valdheim CM, Vannier AM, Hemenway LS, Greenberg DP, Ward JI. Epidemiology of invasive pneumococcal diseases in Southern California: Implications for the design and conduct of a pneumococcal conjugated vaccine efficacy trial. J Infect Dis 1996;174:752-759.
2. Kronenberg CB, Hoffman RE, Lezotte DC, Marine WM. Invasive penicillin-resistant pneumococcal infections: A prevalence and historical cohort study. Emergin Infect Dis 1996;2:121-124.
3. Butler JC, Hoffman J, Cetron MS, Elliot JA, Facklam RR, Brosman RF et al. The continental emergence of drug-resistant Streptococcus pneumoniae in the United States:An updating from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J Infect Dis 1996; 174:986-993.
4. De Velasco EA, Verheul FM, Verhoef J, Snippe H. Streptococcus pneumoniae: Virulence factors, pathogenesis, and vaccines. Microbiol Rev 1995; 59:591-603.
5. Klugman KP. Pneumococcal resistance and antibiotics. Clin Microbiol Rev 1990;3:171-196.
6. Tomasz A. Antibiotic resistance in Streptococcus pneumoniae. Clin Infect Dis 1997; 24suppl 1:85-88.
7. Campbell D, Silberman R. Drug-resistant Streptococcus pneumoniae. Clin Infect Dis 1998;26:1188-1195.
8. Friedland IR, Istre GR. Management of penicillin-resistant pneumococcal infections. Pediatr Infect Dis J 1992;11:433-435.
9. Tan TQ, Mason EO, Kaplan SL Systemic infections due to a Streptococcus pneumoniae relatively resistant to penicillin in a childrens hospital: Clinical management and outcome. Pediatrics 1992;90:928-933.
10. Friedland IR, McCracken GH Jr. Management of infections caused by antibiotic resistant Streptococcus pneumoniae. N Engl J Med 1994;331: 377-382.
11. American Academy of Pediatrics: Committee on Infectious Diseases. Therapy for children with invasive pneumococcal infections. Pediatrics 1997;99:289-299.
12. Lutsar I, McCracken GH Jr, Friedland IR. Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis 1988;27:1117-1129.
13. Ruoff KL, Whiley RA, Beighton D. Streptococcus. En: Murray RR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, ed. Manual of clinical microbiology. 7a. edición. Washington, D.C:ASM Press, 1999:283-296.
14. Jacobs MR, Gaspar MN, Robin-Browner RM, Koornhof HJ. Antimicrobial susceptibility testing of pneumococci. 2. Determination of optimal disk diffusion test for detection of penicillin G resistance. J Antimicrob Chemother 1980;6:53-64.
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Sixth informational suplement M1150-56. Wayne, PA: National Committee for Clinical Laboratory Standards, 1995.
16. National Committee for Clinical Laboratory Standards. Minimum inhibitory concentrations (MIC) Interpretative standards (μg/ml) for Streptococcus spp., Table 2C. M100-S7. Wayne, PA: National Committee for Clinical Laboratory Standards, 1997;17(2).
17. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: An overview. Clin Infect Dis 1992;15:77-83.
18. Friedland IR. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin susceptible pneumococcal disease. Pediatr infect Dis J 1995;14:885-890.
19. Doern TGV, Pfaller MA, Kugler K, Freeman J, Jones RN. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from SENTRY Antimicrobial Surveillance Program. Clin Infect Dis 1998;27:764-770.
20. Mufson MA. Editorial response: Penicillin-resistant Streptococcus pneumoniae increasingly threatens the patient and challenges the physician. Clin Infect Dis 1998;27:771-773.
21. Guiscafré GH, García MM, Trejo PA, García M, Hernández VR, Muñoz HO. Frecuencia de Haemophilus influenzae resistente a ampicilina y de Streptococcus pneumoniae resistente a penicilina en portadores sanos. Arch Invest Med Mex 1981;12:141-151.
22. Calderón JE, Echániz AG, Conde-Glez CJ, Rivera SR, Barriga AG, Solórzano SF et al. Resistencia y serotipificación de 83 cepas de Streptococcus pneumoniae aisladas de niños portadores asintomáticos y enfermos. Bol Med Hosp Infant Mex 1993;50:854-859.
23. Deeks SL, Palacio R, Ruvinsky R, Kertesz DA, Hortal M, Rossi A et al. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. Pediatrics 1999;103:409-413.
24. Arditi M, Mason EO, Bradley JS, Tan TQ, Barson WJ, Schutze GE et al. Three-year multicenter surveillance of pneumococcal meningitis in children: Clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998;102:1087-1096.
25. Kaplan SL, Mason EO, Barson WJ, Wald ER, Arditi M, Tan TQ et al. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics 1998;102:538-545.
26. Pallares R, Liñares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333: 474-480.
27. García-Leoni ME, Cercenado E, Rodeño P, Bernaldo de Quirós CL, Martínez-Hernández D, Bouza E. Susceptibility of Streptococcus pneumoniae to penicillin: A prospective microbiological and clinical study. Clin Infect Dis 1992,14:427-435.
28. Chiou CC, Liu YC, Huang TS, Hwang WK, Wang JA, Lin HH, et al. Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan. J Clin Microbiol 1998;36:1933-1937.
29. Lee HJ, Park JY, Jang SH, Kim JH, Kim EC, Choi KW. High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a University Hospital in Korea. Clin Infect Dis 1995; 20:826-835.
30. Choi EH, Lee HJ. Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children. Clin Infect dis 1998;26:1346-1354.
31. Friedland IR, Klugman KP. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet 1992;339:405-408.
32. 197 in United States infants. Pediatrics 1998;101:604-609.